Of note, several studies have indeed demonstrated that PD-L1 expression could be increased in tumor cells following HDACi treatment [32,33], while accumulating studies have shown that blockade of PD-1/PD-L1 ligation promotes anti-tumor T cell activity [33,34]. Here, CD274 is linked to neoplasm.